Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

Cukurova Med J. 2016; 41(1): 112-120


Effect of isoflavones on atherosclerosis in peritoneal dialysis patients

Fatih Şahpaz, Ayhan Doğukan, Mustafa Neçati Dağlı.

Abstract
Purpose: Cardiovascular disease is an important cause of morbidity and mortality in patients with renal failure. Patients with chronic renal failure are significantly susceptible to atherosclerosis. Our aim is to investigate the effect of isoflavone upon atherosclerosis and inflammation in continuos ambulatory peritoneal dialysis patients.
Material and Methods: Fifty eight patients undergoing peritoneal dialysis were enrolled in the study. The Patients have been separated into two groups. The first group with a plasebo, the second group with 40 mg soy isoflavones (Isoflavin®, Mikro-Gen) 2 times per day was given to patients during 12 weeks. Two of them because of gastrointestinal side effects leaved the study and the study was completed with 56 patients. Before and after the treatment of isoflavone total cholesterol, triglyceride, LDL cholesterol, HDL cholesterol, hs-CRP, homocysteine, intima-media thickness, arterial stiffness values were measured and statistical analyses was made.
Results: The levels of intima-media thickness, arterial stiffness and one of the inflammation marker hs-CRP was statistically lower after the treatment with isoflavones than the beginning of treatment.
Conclusion: Finally; it can be supplied useful effects on inflammatory and atherosclerotic process by using of isoflavones which has antilipogenic, antihypertensive and improving vascular health properties in end stage renal disease.

Key words: inflammation, peritoneal dialysis, isoflavone, intima-media thickness



Share this Article


Advertisement
Oxidants and Antioxidants in Medical Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons